1 / 9

Blood Market is estimated to reach $45,982 million by 2023, growing at a CAGR of 4.6% to 2023

North America is expected to dominate the global blood market during the forecast period. However, the market is growing at a faster rate in the developing countries, owing to the increase in demand for blood & blood components for faster recovery of patients who have undergone surgery, injury, or suffer from diseases, and improvement in the healthcare facilities.

swati_tamhankar
Download Presentation

Blood Market is estimated to reach $45,982 million by 2023, growing at a CAGR of 4.6% to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Blood Market is estimated to reach $45,982 million by 2023, growing at a CAGR of 4.6% to 2023

  2. BLOOD MARKET “Blood Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the global blood market was valued at $33,500 million in 2016, and is projected to reach $45,982 million by 2023, registering a CAGR of 4.6% from 2017 to 2023. The blood therapeutics segment contributed the highest share in 2016, owing to the increase in the demand for various plasma proteins for the recovery of patients. Access Full Summary at: https://www.alliedmarketresearch.com/blood-market Increase in geriatric population, rise in incidence in trauma cases, technological advancement in medical technology for donor screening, and advancement in blood transfusion instruments are the major factors that drive the market growth. However, minimal invasive technology, which no longer need the blood transfusion, restrains the market growth. Improvement in the healthcare facilities in Asia-Pacific provide growth opportunities for the market.

  3. BLOOD MARKET The blood market products include whole blood collection, source plasma collection, blood therapeutics, blood typing products, blood screening, and blood processing equipment & associated products. Increase in geriatric population, rise in trauma cases, technological advancement in medical technology for donor screening, and advancement in blood transfusion instruments drive the market growth. However, rise in minimal invasive technology, which no longer require the blood transfusion hamper the market growth. Increase in peripheral nerve injuries and improvement in the healthcare facilities in Asia-Pacific provide growth opportunities for the market. Blood & blood component banks contributed the highest share in 2016, owing to the increase in the demand for using equipment for the blood processing and for segregation of the blood components. North America accounted for significant share in the global market in 2016, owing to an established healthcare industry and rise in number of patient population requiring blood & blood components. Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/2297

  4. BLOOD MARKET • Key Benefits for Stakeholders • The study provides an in-depth analysis of the global blood market and current trends and future estimations to elucidate the imminent investment pockets. • The report provides a quantitative analysis of the industry from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities. • Extensive analysis of the market based on surgeries and products elucidates various trends and prevailing opportunities across segments. • Key market players operating are profiled to determine the competitive outlook of the market by studying the different products of the companies and their developments. • The key players profiled in the report include Abbott Laboratories, Baxter International Inc., Becton, Dickinson & Co., CSL Behring, Immucor, Novartis, Novo Nordisk, Ortho Clinical Diagnostics, Roche Diagnostics, and Grifols International SA. • List of the other players (not included in the report) Medimmune (AstraZeneca), Fresenius Kabi, Macopharma, Nipro Medical Corporation, Sarstedt AG & Co., and Thermo Fisher Scientific, Inc.

  5. BLOOD MARKET Blood Market Key Segments: By End User By Product • Whole Blood Collection • Source Plasma Collections • Blood Therapeutics • Blood Typing Products • Blood Screening • Blood Processing Equipment & Associated Products • Blood & Blood Component Bank • Diagnostic Laboratories • Ambulatory Surgical Centers • Hospitals • Others (Academic Institutes & Research Laboratories)

  6. BLOOD MARKET By Geography North America Europe Asia-Pacific LAMEA

  7. BLOOD MARKET The major companies profiled in the report include Abbott Laboratories, Baxter International Inc., Becton, Dickinson & Co., CSL Behring, Immucor, Novartis, Novo Nordisk, Ortho Clinical Diagnostics, Roche Diagnostics, and Grifols International SA. Do Purchase Report: https://www.alliedmarketresearch.com/purchase-enquiry/2297

  8. BLOOD MARKET Contact:Shriram Dighe5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesToll Free: +1-800-792-5285UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1⟨855⟩550-5975help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com

  9. BLOOD MARKET Thank You! For More Details Visit us at https://www.alliedmarketresearch.com Follow Us On

More Related